PRESSR: Kleem secures $26 million in funding to boost regional growth of healthcare payment solutions

Abu Dhabi, UAE: Klaim , a leading healthcare payments acceleration solutions company, has secured $10 million in Series A equity financing and a $16 million additional funding round to fuel its regional expansion and transform how healthcare providers access cash flow. This investment will help advance Klaim ’s mission to reshape the healthcare financial landscape by accelerating medical insurance claims payments and improving cash flow for healthcare providers in the Middle East and North Africa.

Since its founding in 2019, Klaim has positioned itself as an innovative and disruptive force in the fintech space, providing a cutting-edge financial solutions platform specializing in healthcare. Leveraging artificial intelligence,

Klaim predicts insurance payment behavior through advanced data analytics and artificial intelligence models. This enables faster and more efficient processing of healthcare claims. Through the new funds, Klaim aims to expand its presence in the UAE, deploy capital in Saudi Arabia, Oman, and other regions, and continuously improve its technology to better serve healthcare providers.

Last year, Klaim announced a strategic milestone in its expansion into Saudi Arabia through a partnership with Tharawat Tuwaiq Financial Company, an asset management firm and financial advisor licensed by the Saudi Capital Market Authority ( CMA ). As part of this collaboration, Tharawat Tuwaiq successfully obtained approval and launched a private, closed-end healthcare fund. The fund, valued at SAR 60 million (approximately USD 16 million), aims to enhance access to working capital solutions tailored to the unique needs of the healthcare sector.
The first transaction under this initiative is scheduled for March 2025, reinforcing Klaim 's commitment to empowering healthcare providers with working capital solutions tailored to the unique needs of the healthcare sector. Additional funds under this program are expected to be disbursed in the second half of 2025, further strengthening long-term support for the healthcare system in Saudi Arabia.
“We are excited to achieve this milestone in our journey,” said Karim Daki, co-founder and CEO of Klaim . “Securing Series A funding is not only a major validation of our vision and business model, but it is also the critical turning point that will enable us to scale rapidly.”

"The healthcare industry often struggles with lengthy payment cycles, creating significant financial pressure on providers. With this new funding, we are well-positioned to accelerate our efforts to deliver seamless and efficient payment solutions that allow healthcare providers to focus on patient care without financial concerns."


Klaim is now expanding its focus on enterprise healthcare systems, enabling larger providers and hospital networks to access payments within 24 hours,” commented Ghafoor Ahmed, co-founder and chief revenue officer of Klaim . “As we expand, our solutions will empower not only small and medium-sized providers but also larger healthcare groups that need reliable payment acceleration solutions to support operational growth. This marks a key milestone in our evolution toward serving the entire healthcare ecosystem at scale.”

Klaim 's Series A financing round was led by Mad'a with significant participation from CDG Invest (the investment arm of the Moroccan Caisse de Deposit et de Governance - CDG ). This financing represents a significant turning point for Klaim as it moves closer to realizing its vision of becoming the regional leader in healthcare payments acceleration.

Through the 212 Founders Program (by CDG Invest ), Managing Director Noufal Fassi Fihri stated, “Karim Daki and Ahmed Ghafour are pioneering founders who have demonstrated a progressive approach, combining their industry expertise with technological innovation to build an innovative healthcare solution, thus addressing a critical gap by solving cash flow problems for medical practitioners. We believe that Klaim ’s financial solutions will scale across different healthcare systems, both locally and regionally, including Morocco.”

“We recognize the transformative impact of Klaim ’s technology in revolutionizing the healthcare and fintech sectors,” said Abdullah Al Othaim, CEO of Mad’a Investment. “By improving healthcare payment processes and providing rapid access to cash flow, Klaim is addressing a critical challenge that has long hindered operational efficiency. We are proud to support Klaim ’s expansion across the GCC, including its strategic entry into Saudi Arabia, and to further strengthen its role as a key driver of digital transformation.”

Through this investment, Klaim aims to expand its operations, enhance its technological capabilities, and continue to form partnerships with leading financial institutions, insurance companies, and healthcare providers to drive digital transformation in the industry.

About Klaim
Clymb is an award-winning financial technology company headquartered in Abu Dhabi Global Market ( ADGM ) with offices across the UAE, Saudi Arabia, and Oman. Since 2019, it has been at the forefront of transforming the healthcare industry by empowering healthcare providers with their working capital requirements, enabling them to grow and thrive.

About Tawaiq Wealth Company
Tharwat Tuwaiq Financial Company, a financial institution regulated and existing under the laws of the Kingdom of Saudi Arabia and the Capital Market Authority as a “Capital Market Institution” under license 23253-02

About 212 Founders (from CDG INVEST )
As the investment arm of the Caisse de Deposit et de Gestion ( CDG ), CDG Invest finances and supports companies with strong ties to Morocco at every stage of their development.
212 Founders was launched in September 2019 by CDG Invest , a leading investment and support program designed to elevate global venture capital ambitions in Morocco. By providing funding, strategic guidance, and operational support, 212 Founders fosters the growth of high-potential startups, positioning Morocco as a key player in the international innovation and entrepreneurship landscape.

About Mada Company
Mada Investment is a growth-driven private equity and venture capital firm that invests in high-potential companies across Saudi Arabia and the Middle East. We partner with ambitious founders and companies poised for growth, providing capital, strategic support, and operational expertise. In addition to financing, we help companies establish a strong local presence and accelerate their growth within the dynamic Saudi market.

-I finish-

#Corporate Data

Disclaimer for the content of press releases
The content of these press releases is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an 'as is' and 'as available' basis and has not been edited in any way. Neither we nor our affiliates are responsible for the accuracy, endorsement, or completeness of the opinions, views, information, or materials contained in this content.
Press releases are provided for informational purposes only; the content does not imply legal, investment, or tax advice or any opinion regarding the suitability, value, or profitability of any particular portfolio or investment strategy. We, or our affiliates, will not be liable for any errors or inaccuracies in the content, or for any actions you take based on such content. You expressly agree and acknowledge that you bear full responsibility for the use of the information contained in these press releases.
To the extent permitted by applicable law, Refinitiv, its parent, subsidiaries, affiliates, and their respective shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the “Refinitiv Parties”) will not be liable (either jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to: lost profits, lost savings or revenue, whether caused by negligence, tort, contract or other liability theories, even if the Refinitiv Parties have been advised of the possibility of any such damages and losses or had actually anticipated their occurrence.